Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Verification Network Update: Less than 60 Days Remain
Industry and service providers continue to work to implement the Drug Supply Chain Security Act’s (DSCSA) serialized saleable return milestone. With the end of FDA-granted enforcement discretion ending on November 27, 2020, and the industry simultaneously responding to COVID-19, it is all hands on deck to reach the compliance finish line.
One Year Later: Good Distribution Practices Program
Chuck Forsaith, Vice President of HDA’s Pharmaceutical Cargo Security Coalition, and Henry Moran, Director of ASC Associates, have collaborated and worked within the U.S. pharmaceutical transportation industry for over 20 years.
HDA Statement on the PREVENT Pandemics Act
The Healthcare Distribution Alliance (HDA) applauds the leadership of Senate Health, Education, Labor, and Pensions (HELP) Committee’s Chairwoman Murray (D-Wash.) and Ranking Member Burr (R-N.C.) for introducing the Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act), a bipartisan public health effort to build stronger national medical preparedness and response systems in the wake of the COVID-19 pandemic. The overwhelming support for the legislation during the HELP Committee markup today, March 15, showed that Congress is making significant, positive steps towards reforms necessary to ensure the availability of lifesaving pharmaceutical treatments and medical supplies in response to future crises.
Kaminsky and Hatcher To Lead HDA Board of Directors; Syvinski Appointed to Executive Committee
The Healthcare Distribution Alliance (HDA) announced Kirk Kaminsky and Jody Hatcher will serve a second year as Chairman and Vice Chairman, respectively, of the HDA Board of Directors.